Recently, Akalin et al.(1) reported a 28% mortality among kidney-transplant patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Two of the 10 patients who died had been transplanted within the previous 5 weeks. During the coronavirus disease (COVID)-19 outbreak, kidney transplant programs were suspended in several countries(2) . Although the pandemic is still ongoing, the stop of lockdown has prompted several transplant centers to restart kidney transplantation programs. It is recommended to consider that donors and recipients are screened for SARS-CoV-2 before transplantation by means of nuclear acid tests with or without chest CT scans.